Clinical Trial Update: Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients

View source ↗

Summary

Pfizer-sponsored study evaluating predictors of response to tofacitinib in rheumatoid arthritis has completed data collection, with results posted on 2025-06-08…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2025-06-08